(Total Views: 216)
Posted On: 03/29/2019 6:44:32 PM
Post# of 154238
Re: ClosetInvestor #1480
Cheap.....$20-30K per the source below. I agree, but maybe they knew this was an easy sell and it was mentioned a couple times back in January and early February. This has been pretty quite and if there is any substance to this SA article, it may be the reason why....$NSTG needed to raise additional funds to close the deal?
https://510kfda.com/pages/fda-510k-costs
IMO they have more going on than they (NP, RP and the few in the background) and the hours in the day can handle. While $$ is much needed, so is leronlimab for cancer patients and they knew that someone else would be selling this test....and maybe they even submitted the 510(k) documents, just never announced it?
https://510kfda.com/pages/fda-510k-costs
IMO they have more going on than they (NP, RP and the few in the background) and the hours in the day can handle. While $$ is much needed, so is leronlimab for cancer patients and they knew that someone else would be selling this test....and maybe they even submitted the 510(k) documents, just never announced it?
(0)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
